Jefferies Raises Price Target to $22: CORZ Stock Update
PorAinvest
martes, 19 de agosto de 2025, 3:54 pm ET1 min de lectura
CORZ--
At CoreWeave’s current price of $99.97, the all-stock deal values Core Scientific shares at roughly $12.35, well below Jefferies’ estimated fair value of $16 to $23. The agreed exchange ratio of 0.1235 means the implied Core Scientific value fluctuates with CoreWeave’s share price swings. If CoreWeave’s stock doesn’t recover ahead of the vote, Jefferies sees room for renegotiation, potentially raising the exchange ratio to 0.16 to 0.20 to bring the implied valuation of CORZ shares back within the $16 to $23 range.
Jefferies analyst Jonathan Petersen maintains a "Buy" rating for Core Scientific and raised the price target from $16.00 to $22.00, a 37.50% increase. The average target price for CORZ is $18.84 with a high estimate of $24.10 and a low estimate of $15.00, implying an upside of 33.33% from the current price of $14.13. The average brokerage recommendation is currently 2.3, indicating an "Outperform" status.
The merger’s success is tied to CoreWeave’s stock performance, with some investors expecting the deal to fail due to the current undervaluation. If CoreWeave's stock doesn’t recover, Jefferies suggests a higher exchange ratio or a collar provision to stabilize the deal against further volatility.
References:
[1] https://au.finance.yahoo.com/news/core-scientific-faces-valuation-disconnect-144739979.html
[2] https://www.coindesk.com/markets/2025/08/18/core-scientific-faces-valuation-disconnect-pt-hiked-to-usd22-jefferies
CRWV--
Jefferies analyst Jonathan Petersen has maintained a "Buy" rating for Core Scientific (CORZ) and raised the price target from $16.00 to $22.00, a 37.50% increase. The average target price for CORZ is $18.84 with a high estimate of $24.10 and a low estimate of $15.00, implying an upside of 33.33% from the current price of $14.13. The average brokerage recommendation is currently 2.3, indicating "Outperform" status.
Core Scientific (CORZ) reported weaker-than-expected revenue but topped adjusted EBITDA estimates in its second-quarter 2025 results. The main focus, however, remains on its proposed merger with AI cloud provider CoreWeave (CRWV), set for a shareholder vote in the fourth quarter. Investment bank Jefferies has highlighted significant valuation discrepancies in the deal.At CoreWeave’s current price of $99.97, the all-stock deal values Core Scientific shares at roughly $12.35, well below Jefferies’ estimated fair value of $16 to $23. The agreed exchange ratio of 0.1235 means the implied Core Scientific value fluctuates with CoreWeave’s share price swings. If CoreWeave’s stock doesn’t recover ahead of the vote, Jefferies sees room for renegotiation, potentially raising the exchange ratio to 0.16 to 0.20 to bring the implied valuation of CORZ shares back within the $16 to $23 range.
Jefferies analyst Jonathan Petersen maintains a "Buy" rating for Core Scientific and raised the price target from $16.00 to $22.00, a 37.50% increase. The average target price for CORZ is $18.84 with a high estimate of $24.10 and a low estimate of $15.00, implying an upside of 33.33% from the current price of $14.13. The average brokerage recommendation is currently 2.3, indicating an "Outperform" status.
The merger’s success is tied to CoreWeave’s stock performance, with some investors expecting the deal to fail due to the current undervaluation. If CoreWeave's stock doesn’t recover, Jefferies suggests a higher exchange ratio or a collar provision to stabilize the deal against further volatility.
References:
[1] https://au.finance.yahoo.com/news/core-scientific-faces-valuation-disconnect-144739979.html
[2] https://www.coindesk.com/markets/2025/08/18/core-scientific-faces-valuation-disconnect-pt-hiked-to-usd22-jefferies

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios